Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.

MLA

Murakami, Takashi, et al. “Color-Coded Intravital Imaging Demonstrates a Transforming Growth Factor-β (TGF-β) Antagonist Selectively Targets Stromal Cells in a Human Pancreatic-Cancer Orthotopic Mouse Model.” Cell Cycle, vol. 16, no. 10, May 2017, pp. 1008–14. EBSCOhost, https://doi.org/10.1080/15384101.2017.1315489.

APA

Murakami, T., Hiroshima, Y., Miyake, K., Hwang, H. K., Kiyuna, T., DeLong, J. C., Lwin, T. M., Matsuyama, R., Mori, R., Kumamoto, T., Chishima, T., Tanaka, K., Ichikawa, Y., Bouvet, M., Endo, I., & Hoffman, R. M. (2017). Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model. Cell Cycle, 16(10), 1008–1014. https://doi.org/10.1080/15384101.2017.1315489

Chicago

Murakami, Takashi, Yukihiko Hiroshima, Kentaro Miyake, Ho Kyoung Hwang, Tasuku Kiyuna, Jonathan C. DeLong, Thinzar M. Lwin, et al. 2017. “Color-Coded Intravital Imaging Demonstrates a Transforming Growth Factor-β (TGF-β) Antagonist Selectively Targets Stromal Cells in a Human Pancreatic-Cancer Orthotopic Mouse Model.” Cell Cycle 16 (10): 1008–14. doi:10.1080/15384101.2017.1315489.